Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma(,,)

OBJECTIVE: Uterine carcinosarcoma (CS) is a rare uterine tumor with an extremely poor prognosis. In the adjuvant setting, efficacy has been shown with radiotherapy (RT), systemic chemotherapy, or both. This is the first report describing the efficacy and toxicity of adjuvant ifosfamide or ifosfamide...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Einstein, Mark H., Klobocista, Merieme, Hou, June Y., Lee, Stephen, Mutyala, Subhakar, Mehta, Keyur, Reimers, Laura L., Kuo, Dennis Y.-S., Huang, Gloria S., Goldberg, Gary L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787514/
https://ncbi.nlm.nih.gov/pubmed/22055846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.008
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы